Literature DB >> 29505158

ABCA3 missense mutations causing surfactant dysfunction disorders have distinct cellular phenotypes.

Ulrike Schindlbeck1, Thomas Wittmann1, Stefanie Höppner1, Susanna Kinting1, Gerhard Liebisch2, Jan Hegermann3, Matthias Griese1.   

Abstract

Mutations in the ATP-binding cassette subfamily A member 3 (ABCA3) gene are the most common monogenetic cause of surfactant dysfunction disorders in newborns and interstitial lung diseases in children and young adults. Although the effect of mutations resulting in truncated or incomplete proteins can be predicted, the consequences of missense variants cannot be as easily. Our aim was to investigate the intracellular handling and disturbance of the cellular surfactant system in a stable cell model with several different clinically relevant ABCA3 missense mutations. We found that the investigated missense mutations within the ABCA3 gene affect surfactant homeostasis in different ways: first by disrupting intracellular ABCA3 protein localization (c.643C > A, p.Q215K; c.2279T > G, p.M760R), second by impairing the lipid transport of ABCA3 protein (c.875A > T, p.E292V; c.4164G > C, p.K1388N), and third by yet undetermined mechanisms predisposing for the development of interstitial lung diseases despite correct localization and normal lipid transport of the variant ABCA3 protein (c.622C > T, p.R208W; c.863G > A, p.R288K; c.2891G > A, p.G964D). In conclusion, we classified cellular consequences of missense ABCA3 sequence variations leading to pulmonary disease of variable severity. The corresponding molecular pathomechanisms of such ABCA3 variants may specifically be addressed by targeted treatments.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  ATP-binding cassette transporters; human ABCA3 protein; interstitial lung diseases; respiratory distress syndrome of the newborn; surfactant dysfunction

Mesh:

Substances:

Year:  2018        PMID: 29505158     DOI: 10.1002/humu.23416

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  7 in total

Review 1.  Genetic causes of surfactant protein abnormalities.

Authors:  Lawrence M Nogee
Journal:  Curr Opin Pediatr       Date:  2019-06       Impact factor: 2.856

2.  The clinical course of interstitial lung disease in an adult patient with an ABCA3 homozygous complex allele under hydroxychloroquine and a review of the literature.

Authors:  Marie Legendre; Xavier Darde; Marion Ferreira; Sandra Chantot-Bastaraud; Marion Campana; Laurent Plantier; Nadia Nathan; Serge Amselem; Annick Toutain; Patrice Diot; Sylvain Marchand-Adam
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-06-29       Impact factor: 1.803

3.  Functional Genomics of ABCA3 Variants.

Authors:  Jennifer A Wambach; Ping Yang; Daniel J Wegner; Hillary B Heins; Cliff Luke; Fuhai Li; Frances V White; F Sessions Cole
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

4.  ABCA3 gene mutations shape the clinical profiles of severe unexplained respiratory distress syndrome in late preterm and term infants.

Authors:  Jianhui Wang; Juan Fan; Yuting Zhang; Lie Huang; Yuan Shi
Journal:  Transl Pediatr       Date:  2021-02

5.  Cryo-EM structures of the human surfactant lipid transporter ABCA3.

Authors:  Tian Xie; Zike Zhang; Jian Yue; Qi Fang; Xin Gong
Journal:  Sci Adv       Date:  2022-04-08       Impact factor: 14.136

6.  Case Report: Report of Two Cases of Interstitial Lung Disease Caused by Novel Compound Heterozygous Variants in the ABCA3 Gene.

Authors:  Fang Chen; Zhiwei Xie; Victor Wei Zhang; Chen Chen; Huifeng Fan; Dongwei Zhang; Wenhui Jiang; Chunli Wang; Peiqiong Wu
Journal:  Front Genet       Date:  2022-04-06       Impact factor: 4.772

7.  Neonatal respiratory failure due to novel compound heterozygous mutations in the ABCA3 lipid transporter.

Authors:  Zoltán N Oltvai; Eric A Smith; Katie Wiens; Lawrence M Nogee; Mark Luquette; Andrew C Nelson; Kathryn A Wikenheiser-Brokamp
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-06-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.